Cargando...
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
BACKGROUND: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid [ICS] plus long-acting β(2)-agonist bronchodilator [LABA] plus long-acting muscarinic antagonist) differ from Global initiative for chronic Obstructive Lung Disease [GOLD] and National Institute for H...
Gardado en:
| Publicado en: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621207/ https://ncbi.nlm.nih.gov/pubmed/26527869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S91694 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|